dalteparin has been researched along with Irritable Bowel Syndrome in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Irritable Bowel Syndrome: A disorder with chronic or recurrent colonic symptoms without a clearcut etiology. This condition is characterized by chronic or recurrent ABDOMINAL PAIN, bloating, MUCUS in FECES, and an erratic disturbance of DEFECATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Trepanier, M | 1 |
| Alhassan, N | 1 |
| Sabapathy, CA | 1 |
| Liberman, AS | 1 |
| Charlebois, P | 1 |
| Stein, BL | 1 |
| S Feldman, L | 1 |
| Lee, L | 1 |
1 other study available for dalteparin and Irritable Bowel Syndrome
| Article | Year |
|---|---|
Cost-Effectiveness of Extended Thromboprophylaxis in Patients Undergoing Colorectal Surgery from a Canadian Health Care System Perspective.
Topics: Anticoagulants; Chemoprevention; Colectomy; Colonic Neoplasms; Cost-Benefit Analysis; Decision Suppo | 2019 |